While RAD51 displays a protective role, scholars have found that RAD51 is overexpressed in several tumor types, including breast, pancreatic, head and neck, prostate, non-small cell lung, and esophageal cancers [5, 6]. This evidence concerns the gene RAD51 and esophageal cancer.